Chromatin is the therapeutic target for DNA-binding medicinal agents, yet we know substantially more about the interaction of drugs with naked DNA. Current research is unraveling a dynamic gene- and transcription state-dependent structure for human chromatin and also unveiling differences in nucleosome ...